CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PUBLICATIONS

  1. Celli B, Crater G, Kilbride S, Mehta R, Tabberer M, Kalberg CJ and Church A. Once-daily umeclidinium/vilanterol 125/25 mcg in COPD: A randomized, controlled study. Chest 2014 Jan 2. doi: 10.1378/chest.13-1579. [Epub ahead of print]
  2. Polkey MI, Spruit MA, Wouters E, Edwards LD, Tal-Singer R and Celli B. Reply: Minimal or maximal clinically important difference: Using death to define MCID. American Journal of Respiratory and Critical Care Medicine 2013;187:1392.
  3. Casaburi R, Celli B, Crapo J, Criner G, Croxton T, Gaw A, Jones P, Kline-Leidy N, Lomas DA, Merrille D, Polkey M, Rennard S, Sciurba F, Tal-Singer R, Turino G, Vestbo J and Walsh J. The COPD Biomarker Qualification Consortium (CBQC). COPD 2013;10:367-77.
  4. Faner R, Tal-Singer R, Riley JH, Celli B, Vestbo J, Macnee W, Bakke P, Calverley PM, Coxson H, Crim C, Edwards LD, Locantore N, Lomas DA, Miller BE, Rennard SI, Wouters EF, Yates JC, Silverman EK and Agusti A. Lessons from ECLIPSE: A review of COPD biomarkers. Thorax 2013;69(7):666-72.
  5. Chen W, Brehm JM, Boutaoui N, Soto-Quiros M, Avila L, Celli BR, Bruse S, Tesfaigzi Y and Celedón JC. Native American ancestry, lung function and chronic obstructive pulmonary disease in Costa Ricans. Chest 2013;145(4):704-10.
  6. Rutten EP, Calverley PM, Casaburi R, Agusti A, Bakke P, Celli B, Coxson HO, Crim C, Lomas DA, Macnee W, Miller BE, Rennard SI, Scanlon PD, Silverman EK, Tal-Singer R, Vestbo J, Watkins ML and Wouters EF. Changes in body composition in patients with chronic obstructive pulmonary disease: Do they influence patient-related outcomes? Annals of Nutrition and Metabolism 2013;63(3):239-47.
  7. Diaz AA, Come CE, Mannino DM, Pinto-Plata V, Divo MJ, Bigelow C, Celli B and Washko GR. Obstructive lung disease in Mexican-Americans and non-Hispanic Whites: An analysis of diagnosis and survival in the NHANES III follow-up study. Chest 2013;145(2):282-9.
  8. Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V and Vestbo J. Six-minute-walk test in chronic obstructive pulmonary disease: Minimal clinically important difference for death or hospitalization. American Journal of Respiratory and Critical Care Medicine 2013;187:382-6.
  9. Kelly E, Owen CA, Pinto-Plata V and Celli BR. The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 2013;7:57-64.
  10. Coxson HO, Dirksen A, Edwards LD, Yates JC, Agusti A, Bakke P, Calverley P, Celli B, Crim C, Duvoix A, Fauerbach PN, Lomas D, MacNee W, Mayer R, Miller B, Muller N, Rennard S, Silverman S, Tal-Singer R, Wouters E and Vestbo J. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: A prospective analysis from the ECLIPSE study. The Lancet Respiratory Medicine 2013;1:129-36.
  11. Casanova C, Aguirre-Jaíme A, de Torres J, Pinto-Plata V, Baz R, Marin J, Divo M, Cordoba E, Basaldua S, Cote C and Celli B. Longitudinal assessment in COPD patients: Multidimensional variability and outcomes. European Respiratory Journal 2013;43(3):745-53.
  12. Agusti A, Edwards LD, Celli B, MacNee W, Calverley PM, Mullerova H, Lomas DA, Wouters E, Bakke P, Rennard S, Crim C, Miller BE, Coxson HO, Yates JC, Tal-Singer R and Vestbo J. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. European Respiratory Journal 2013;42:636-46.
  13. Zagaceta J, Zulueta JJ, Bastarrika G, Colina I, Alcaide AB, Campo A, Celli BR and de Torres JP. Epicardial adipose tissue in patients with chronic obstructive pulmonary disease. PLoS One 2013;8(6):e65593.
  14. Janssens W, Liu Y, Liu D, Kesten S, Tashkin DP, Celli BR and Decramer M. Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT). Respiratory Medicine 2013;107:1409-16.
  15. Come C, Diaz AA, Curran-Everett D, Muralidhar N, Hersh CP, Zach JA, Schroeder J, Lynch DA, Celli B and Washko GR. Characterizing functional lung heterogeneity in COPD using reference equations for CT scan-measured lobar volumes. Chest 2013;143:1607-17.
  16. de Torres JP, Casanova C, Marin JM, Zagaceta J, Alcaide AB, Seijo LM, Campo A, Carrizo S, Montes U, Cordoba-Lanus E, Baz-Davila R, Aguirre-Jaime A, Celli BR and Zulueta JJ. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: A pilot study. Respiratory Medicine 2013;107:702-7.
  17. Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluna JJ, Torres JP, Martinez-Camblor P, Miravitlles M, Celli BR and Soriano JB. Multicomponent indices to predict survival in COPD: The Collaborative cohorts to assess multicomponent indices of COPD in Spain-COCOMICS study. European Respiratory Journal 2013;42:323-32.
  18. Kim DK, Cho MH, Hersh CP, Lomas DA, Miller BE, Kong X, Bakke P, Gulsvik A, Agusti A, Wouters E, Celli B, Coxson H, Vestbo J, MacNee W, Yates JC, Rennard S, Litonjua A, Qiu W, Beaty TH, Crapo JD, Riley JH, Tal-Singer R and Silverman EK. Genome-wide association analysis biomarkers in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012;186:1238-47.
  19. Kelly E, Owen CA, Pinto-Plata V and Celli BR. The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 2013;7:57-64.
  20. Polkey MI, Spruit MA, Edwards LK, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agusti A, Blakke PS, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EF and Celli B. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) study investigators. American Journal of Respiratory and Critical Care Medicine 2013;187:382-6.
  21. Kostikas K, Bakakos P, Papiris S, Stolz D and Celli BR. Systemic biomarkers in the evaluation and management of COPD patients: Are we getting closer to clinical applications. Current Drug Targets 2013;14:177-91.
  22. Soriano JB, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cutaluna JJ, de Torres JP, Martinez-Camblor P, Miravitlles M, Celli BR and Marin JM. Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. Chest 2013; 143:694-702.
  23. Cooper CB, Celli BR, Jardim JR, Wise RA, Legg D, Guo J and Kesten S. Treadmill endurance during 2 years treatment with tiotropium in patients with COPD: A randomized trial. Chest 2013;144:490-7.
  24. Halpin DM, Decramer M, Celli B, Kesten S., Liu D and Tashkin DP. Exacerbation frequency and course of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2012;7:653-61.
  25. Vestbo J, Anderson J, Brook RD, Calverley PM, Celli BR, Crim C, Haumann B, Martinez F, Yates J and Newby DE. The study to understand mortality and morbidity in COPD (SUMMIT) study protocol. European Respiratory Journal 2013;41:1017-22.
  26. Divo M, Cote C, deTorres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G and Celli B. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012;186:155-61.
  27. Albert P, Agusti A, Edwards L, Tal-Singer R, Yates J, Bakke P, Celli BR, Coxson HO, Crim C, Lomas DA Macnee W, Miller B, Rennard S, Silverman EK, Vestbo J, Wouters E and Calverley P. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax 2012;67:701-8.
  28. Celli BR, Decramer M, Lystig T, Kesten S and Tashkin DP. Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease. Respiratory Research 2012;13:66.
  29. Pinto-Plata V, Casanova C, Mullerova H, de Torres JP, Corado H, Varo N, Cordova E, Zeineldine S, Paz H, Baz R, Divo M, Cortopassi F and Celli BR. Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD. Respiratory Research 2012;13:71.
  30. Doyle TW, Washko G, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Divo M., Celli BR, Sciurba FC, Silverman EK, Hatabu H, Rosas IO and Hunninghake GM. Interstitial lung abnormalities and reduced exercise capacity. American Journal of Respiratory and Critical Care Medicine 2012;185:756-62.
  31. Agusti A, Edwards LK, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, Mayer RJ and Celli B. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLoS One 2012;7(5):e37483.
  32. Tashkin DP, Celli BR, Decramer M, Lystig T, Liu D and Kesten S. Efficacy of tiotropium in COPD patients with FEV> 60% participating in the UPLIFT trial. COPD 2012;9:289-96.
  33. Come CE, Divo MJ, San Jose Estepar R, Sciurba FC, Criner GJ, Marchetti N, Scharf SM, Mosenifar Z, Make BJ, Keller CA, Minai OA, Martinez FJ, Han MK, Reilly JJ, Celli BR and Washko GR. Lung deflation and oxygen pulse in COPD: Results from the NETT randomized trial. Respiratory Medicine 2012;106:109-19.
  34. Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, Lomas DA, Duvoix A, Macnee W, Rennard S, Silverman E, Vestbo J, Wouters E and Agusti AA. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012;15:1065-72.
  35. Celli BR. Treatment of the stable patient with chronic obstructive pulmonary disease. In: Spiro, Silvestri, August, eds. Clinical Respiratory Medicine, 4th ed. 2012;7(42):553-61.
  36. Qiu W, Cho MH, Riley JH, Anderson WH, Singh D, Bakke P, Gulsvik A, Litonjua AA, Lomas DA, Crapo JD, Beaty TH, Celli BR, Rennard S, Tal-Singer R, Fox SM, Silverman EK and Hersh CP. Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One 2011;6(9):e24395.
  37. Kesten S, Celli B, Decramer M, Liu D and Tashkin D. Adverse health consequences in COPD patients with rapid decline in FEV1-evidence from the UPLIFT trial. Respiratory Research 2011;12:129-33.
  38. Agusti A and Celli B. Avoiding confusion in COPD from risk factors to phenotypes to measures of diseases characterization. European Respiratory Journal 2011;38:749-51.
  39. Vestbo J, Edwards LK, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman ED, Tal-Singer R, Wouters E and Rennard SI. Changes in forced expiratory volume in 1 second over time in COPD. New England Journal of Medicine 2011;365:1184-92.
  40. Cho MH, Castaldi PJ, Wan ES, Siedlinski M, Hersh CP, Demeo DL, Himes BE, Sylvia JS, Klanderman BJ, Ziniti JP, Lange C, Litonjua AA, Sparrow D, Regan EA, Make BJ, Hokanson JE, Murray T, Hetmanski JB, Pillai SG, Kong X, Anderson WH, Tal-Singer R, Lomas DA, Coxson HO, Edwards LD, Macnee W, Vestbo J, Yates JC, Agusti A, Calverley PM, Celli B, Crim C, Rennard S, Wouters E, Bakke P, Gulsvik A, Crapo JD, Beaty TH and Silverman EK. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Human Molecular Genetics 2012;21:947-57.
  41. Spruit MA, Polkey MI, Celli B, Edwards LK, Watkins ML, Pinto-Plata V, Calverley PM, Tal-Singer R, Agusti A, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Crim CC, Yates J and Wouters EF. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. Journal of the American Medical Directors Association 2012;13:291-7.
  42. de Torres JP, Marin JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, Baz-Davilla R, Zulueta JJ, Aguirre-Jamie A, Saetta M, Cosio MG and Celli BR. Lung cancer in patients with COPD: Incidence and predicting factors. American Journal of Respiratory and Critical Care Medicine 2011;184:913-9.
  43. Casanova C, de Torres JP, Aguirre-Jaime A, Pinto-Plata V, Marin JM, Cordoba E, Baz R, Cote C and Celli BR. The progression of chronic obstructive pulmonary disease is heterogeneous: The experience of the BODE cohort. American Journal of Respiratory and Critical Care Medicine 2011;184:1015-21.
  44. Cooper CB, Anzueto A, Decramer M, Celli B, Tashkin DP, Leimer I and Kesten S. Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials. International Journal of Chronic Obstructive Pulmonary Disease 2011;6:269-75.
  45. Bruse S, Sood A, Petersen H, Liu Y, Leng S, Celedon JC, Gilliland F, Celli B, Belinsky SA and Tesfaigzi Y. New Mexican Hispanic smokers have lower odds of COPD and less decline in lung function than non-Hispanic Whites. American Journal of Respiratory and Critical Care Medicine 2011;184:1254-60.
  46. Jones PW, Anderson JA, Calverley PM, Celli BR, Ferguson GT, Jenkins C, Yates JC, Vestbo J and Spencer MD. Health status in the TORCH study of COPD treatment efficacy and other determinants of change. Respiratory Research 2011;12:71-6.
  47. Halpin DM, Decramer M, Celli B, Kesten S, Leimer I and Tashkin DP. Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trial. Lung 2011;189:261-8.
  48. Jenkins CR, Celli B, Anderson JA, Ferguson GT, Jones PW, Vestbo J, Yates JC and Calverley PM. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH Study. European Respiratory Journal 2012;39:38-45.
  49. de Torres JP, Casanova C, Cote CG, Lopez MV, Diaz O, Maria Marin J, Pinto-Plata V, Montes de Oca M, Aguirre-Jaime A and Celli BR. Six-minute walking distance in women with COPD. COPD 2011;8:300-5.
  50. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Yates JC and Jones PW. Bias due to withdrawal in long-term randomized trials in COPD: Evidence from the TORCH study. The Clinical Respiratory Journal 2011;5(1):44-9.
  51. Celli BR and Vestbo J. The EXACT-Pro: Measuring exacerbations of COPD. American Journal of Respiratory and Critical Care Medicine 2011;183(3):287-8.
  52. Celli BR, Tashkin DP, Rennard SI, McElhattan J and Martin UJ. Bronchodilators responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. Respiratory Medicine 2011;105:1523-30.
  53. Singh D, Fox SM, Tal-Singer R, Plumb J, Bates S, Broad P, Riley JH and Celli B. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers. Thorax 2011;66:489-95.
  54. Crim C, Celli B, Edwards LK, Wouters E, Coxson HO, Tal-Singer R and Claverley PM. Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results. Respiratory Medicine 2011;105:1069-78.
  55. Sin DD, Miller BE, Duvoix A, Man SF, Zhang X, Silverman ED, Connett JE, Anthonisen NA, Wise RA, Tashkin D, Celli BR, Locantore N, MacNee W, Tal-Singer R and Lomas DA. Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2011;183:1187-92.
  56. Maltais F, Celli B, Casaburi R, Porszasz J, Jarreta D., Seoane B and Caracta C. Aclidinium bromide improves exercise endurance, dyspnea and capacity in patients with moderate to severe COPD. American Journal of Respiratory Care and Medicine 2011;105(4);580-7.
  57. Sin DD, Miller B, Duvoix A, Man SF, Zhang X, Silverman EK, Connett JE, Anthonisen NA, Wise RA, Tashkin D, Celli BR, Edwards L, Locantore N, Macnee W, Tal-Singer R and Lomas DA. Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2011;183(9):1187-92.
  58. Celli B. Management Guidelines for COPD. In Hanania NA and Sharafkhaneh A, eds. COPD: A Guide to Diagnosis and Clinical Management. Houston, Texas: Humana Press; 2011:81-98.
  59. Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S and Tashkin D. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respiratory Research 2011;12(1):6.
  60. Cortopassi F, Divo M, Pinto-Plata V and Celli B. Resting handgrip force and impaired cardiac function at rest and during exercise in COPD patients. Respiratory Medicine 2011;105(5):748-54.
  61. de Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, Cordoba-Lanus E, Baz-Davila R, Aguirre-Jaime A and Celli BR. Gender differences in plasma biomarker levels in a cohort of COPD patients: A pilot study. PLoS One 2011;6(1):e16021.
  62. Marin JM, Cote CG, Diaz O, Lisboa C, Casanova C, Lopez MV, Carrizo SJ, Pinto-Plata V, Dordelly LJ, Nekach H and Celli BR. Prognostic assessment in COPD health related quality of life and the BODE index. Respiratory Medicine 2011;105(6):916-21.
  63. Agusti A, Sobradillo P and Celli B. Addressing the complexity of COPD from phenotypes and biomarkers to scale free networks, systems biology and p4 medicine. American Journal of Respiratory and Critical Care Medicine 2011;183(9):1129-37.
  64. Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, Yates JC, Anderson JA, Willits LR and Wise RA. Gender differences in mortality and clinical expressions of patients with COPD: The TORCH experience. On behalf of the investigators of the TORCH study. American Journal of Respiratory and Critical Care Medicine 2011;183(3);317-22.
  65. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC and Vestbo J. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory Research 2010;11(1):122.
  66. Celli BR. Predicators of mortality in COPD. Respiratory Medicine 2010;104(6):773-9.
  67. Celli BR and Halbert RJ. Point: should we abandon FEV1/FVC <0.07 to detect airway obstruction? No. Chest 2010;138(5):1037-40.
  68. Morice AH, Celli B, Kesten S, Lystig T, Tashkin D and Decramer M. COPD in young patients: A pre-specified analysis of the four-year trial of tiotropium. Respiratory Medicine 2010;104(11):1659-67.
  69. Celli BR. The light at the end of the tunnel: Is COPD prevalence changing? European Respiratory Journal 2010;36(4):718-9.
  70. Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP and Decramer M. Tiotropium as a first maintenance drug in COPD: Secondary analysis of the UPLIFT trial. European Respiratory Journal 2010;36(1):65-73.
  71. Marin JM, Soriano JB, Carrizo SJ, Boldova A and Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome. American Journal of Respiratory and Critical Care Medicine 2010;182(3):325-31.
  72. Tashkin D, Celli B, Kesten S, Lystig T and Decramer M. Effect of tiotropium in men and women with COPD: Results of the 4-year UPLIFT trial. Respiratory Medicine 2010;104(10):1495-504.
  73. Celli B. Science at the bedside. Is COPD a respiratory disease with prominent systemic implications or a systemic disease with pulmonary symptoms? In: Donner CF, ed. COPD is/is not a systemic disease? Italia: NOVA Biomedical; 2010:129-154.
  74. Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto-Plata V, Celli BR, Tal-Singer R and Wouters EF. Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort. Respiratory Medicine 2010;104(6):849-57.
  75. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF and Martinez FJ. Chronic obstructive pulmonary disease phenotypes: The future of COPD. American Journal of Respiratory and Critical Care Medicine 2010;182(5):598-604.
  76. Casanova C, de Torres JP, Navarro J, Aguirre-Jaíme A, Toledo P, Cordoba E, Baz R and Celli BR. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2010;182(8):1004-10.
  77. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Crim C, Willits LR, Yates JC and Vestbo J. Cardiovascular events in patients with COPD: TORCH study results. Thorax 2010;65(8):719-25.
  78. Celli B, Decramer M, Leimer I, Vogel U, Kesten S and Tashkin DP. Cardiovascular safety of tiotropium in patients with COPD. Chest 2010;137(1):20-30.
  79. Tashkin DP, Celli B, Kesten S, Lystig T, Mehra S and Decramer M. Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. European Respiratory Journal 2010;35(2):287-94.
  80. Celli B, Decramer M, Kesten S, Liu D, Mehra S and Tashkin DP. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2009;180(10):948-55.
  81. Stockley R, Rennard S, Rabe K and Celli B, eds. Chronic Obstructive Pulmonary Disease London: Blackwell Scientific; 2009.
  82. Celli BR, Marin JM, Cote CG, Aguirre A and Macario CC Prognostic assessment of patients with COPD. The Lancet 2009;374(9705):1885-7.
  83. Keene ON, Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C and Jones PW. Methods for therapeutic trials in COPD: Lessons from the TORCH trial. European Respiratory Journal 2009;34(5):1018-23.
  84. Decramer M, Celli B, Kesten S, Lystig T, Mehra S and Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): A prespecified subgroup analysis of a randomised controlled trial. The Lancet 2009;374:1171-8.
  85. de Torres JP, Casanova C and Celli BR. Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients. European Respiratory Journal 2009;34:776.
  86. Phung OJ, White CM, Baker WL and Coleman CI. Assessing the usefulness of health-related quality-of-life trials: A clinician's perspective using two COPD examples. Annals of Pharmacotherapy 2009;43(9):1496-505.
  87. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J and Celli B. Prevalence and progression of osteoporosis in patients with COPD: Results from the Towards a Revolution in COPD Health study. Chest 2009;136(6):1456-65.
  88. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC and Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009;64(11):939-43.
  89. Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR and Vestbo J. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: Analysis from the randomised, placebo-controlled TORCH study. Respiratory Research 2009;10:59.
  90. Keene ON, Celli B, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC and Calverley PM. Lung function decline in COPD trials. European Respiratory Journal 2009;33:708-9.
  91. Barr RG, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba FC, Stoller JK, Thomashow BM and Turino GM. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. American Journal of Medicine 2009;122:348-55.
  92. Marin JM, Carrizo SJ, Casanova C, Martinez-Camblor P, Soriano JB, Agusti AG and Celli BR Prediction of risk of COPD exacerbations by the BODE index. Respiratory Medicine 2009;103(3):373-8.
  93. Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Willits LR, Yates JC and Vestbo J. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. European Respiratory Journal 2009;34(3):641-7.
  94. Barnes PJ and Celli BR. Systemic manifestations and co-morbidities of COPD. European Respiratory Journal 2009;33:1165-85.
  95. de Torres JP, Cote CG, López MV, Casanova C, Díaz O, Marin JM, Pinto-Plata V, de Oca MM, Nekach H, Dordelly LJ, Aguirre-Jaime A and Celli BR. Gender differences in mortality in patients with COPD. European Respiratory Journal 2009;33:528-35.
  96. Akazawa M, Biddle A and Stearns S. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching. Clinical Therapeutics 2008;30(1):1103-16.
  97. Akazawa M, Stearns S and Biddle A. Assessing treatment effects of inhaled corticosteroid on medical costs among COPD patients: Longitudinal analysis of managed care claims. Health Services Research 2008;43(6):2164-82.
  98. Cooper CB and Celli B. Venous admixture in COPD: Pathophysiology and therapeutic approaches. COPD 2008;5:376-81.
  99. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menioge S and Decramer M. A 4-year trial of tiotripium in chronic obstructive pulmonary disease. New England Journal of Medicine 2008;359:1543-54.
  100. Casanova C, Cote C, Marin JM, Pinto-Plata V, de Torres JP, Aguirre-Jaíme A, Vassaux C and Celli BR. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008;134(4): 746-52.
  101. Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Díaz H, Celli BR and Pinto-Plata VM. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. European Respiratory Journal 2008;32:1275-82.
  102. de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Córdoba-Lanús E, Muros de Fuentes M, Aguirre-Jaime A and Celli BR. C- Reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008;133:1336-43.
  103. García-Talavera I, García CH, Macario CC, de Torres JP, Celli BR and Aguirre-Jaime A. Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO(2) between 60 and 70mmHg. Respiratory Medicine 2008;102:1026-32.
  104. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins C, Jones PW, Vestbo J, Knobil K, Yates JC and Calverley PM. Effect of pharmacotherapy on rate of decline of lung function in COPD: Results from the TORCH Study. American Journal of Respiratory and Critical Care Medicine 2008;178:332-8.
  105. Celli B. Medical Therapy for COPD. In: Voelkel and MacNee, eds. Chronic Obstructive Pulmonary Disease. Hamilton: BC Decker; 2008:375-94.
  106. Cote CG, Pinto-Plata V, Marin JM, Nekach H, Dordelly LJ and Celli BR. The modified BODE Index: Validation with mortality in COPD. European Respiratory Journal 2008;32:1269-74.
  107. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA and Wouters EF. Outcomes for COPD pharmacological trials: From lung function to biomarkers. European Respiratory Journal 2008;31:416-69.
  108. Celli B. What is the best pharmacological treatment to prevent exacerbation of chronic obstructive pulmonary disease? Polish Archives of Internal Medicine 2008;118(4):172-4.
  109. Celli BR, Cote CG, Lareau SC and Meek PM. Predictors of survival in COPD: More than just the FEV1. Respiratory Medicine 2008;102;S27-35.
  110. Celli B and ZuWallack R. Pulmonary rehabilitation. In: Mason, Courtney Broaddus, Murray and Nadel, eds. Textbook of Respiratory Medicine. Philadelphia, PA: Elsevier Saunders; 2008:88:2421-32.
  111. Man SF, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Zhang X, Vessey R, Walker TG, Celli BR and Sin DD. Circulating fibronectin to C-reactive protein ratio and mortality: A biomarker in COPD? European Respiratory Journal 2008;32:1451-7.
  112. Celli BR. Update on the management of COPD. Chest 2008;133:1451-62.
  113. Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C and Kesten S. Bronchodilator responsiveness in patients with COPD. European Respiratory Journal 2008;31:742-50.
  114. Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ and Celli BR. The 6-minute walk distance, peak oxygen uptake and mortality in chronic obstructive pulmonary disease. Chest 2007;132:1778-85.
  115. de Torres JP, Casanova C, de Garcini AM, Jaime AA and Celli BR. COPD heterogeneity: Gender differences in the multidimensional BODE index. International Journal of Chronic Obstructive Pulmonary Disease 2007;2:151-5.
  116. Paz-Diaz H, Montes de Oca M, Lopez JM and Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. American Journal of Physical Medicine and Rehabilitation 2007;86:30-6.
  117. Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R and Celli B. Profiling serum biomarkers in patients with COPD: Associations with clinical parameters. Thorax 2007;62:595-601.
  118. Pinto-Plata VM, Celli-Cruz RA, Vassaux C, Torre-Bouscoulet L, Mendes A, Rassulo J and Celli BR. Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease stage categories and gender. Chest 2007;132:1204-11.
  119. Pinto-Plata VM, Livnat G, Girish M, Cabral H, Masdin P, Linacre P, Dew R, Kenney L and Celli BR. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007;131:37-43.
  120. Celli BR and Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. European Respiratory Journal 2007;29:1224-38.
  121. Cote CG, Zilberberg MD, Mody SH, Dordelly LJ and Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. European Respiratory Journal 2007;29:923-9.
  122. de Torres JP, Casanova C, de Garcini AM, Jaime AA and Celli BR. COPD heterogeneity: Gender differences in the multidimensional BODE index. International Journal of Chronic Obstructive Pulmonary Disease 2007;2:151-5.
  123. Garcia Rio F, Borderias Clau L, Casanova Macario C, Celli BR, Escarrabill Sanglas J, Gonzalez Mangado N, Roca Torrent J and Uresandi Romero F. Air travel and respiratory diseases. Archivos de Bronconeumologia 2007;43:101-25.
  124. Casanova MC and Celli BR. Should we be paying attention to inspiratory capacity? Archivos de Bronconeumologia 2007;43:245-7.
  125. Casanova C, Cote CG, Marin JM, de Torres JP, Aguirre-Jaime A, Mendez R, Dordelly L and Celli BR. The 6-min walking distance: Long-term follow up in patients with COPD. European Respiratory Journal 2007;29:535-40.
  126. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC and Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. New England Journal of Medicine 2007;356:775-89.
  127. Cote CG, Dordelly LJ and Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007;131(3):696-704.
  128. Cote CG and Celli B. New treatment strategies for COPD. Pairing the new with the tried and true. Postgraduate Medicine 2007;117:27-34.
  129. Cote CG and Celli BR. Predictors of mortality in chronic obstructive pulmonary disease. Clinics in Chest Medicine 2007;28:515-24.
  130. Celli BR. Rogers Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. Proceedings of the American Thoracic Society 2006;3:461-5.
  131. Pinto-Plata V, Toso J, Lee K, Bilello J, Mullerova H, De Souza M, Vessey R and Celli B. Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: Correlation with clinical parameters. Proceedings of the American Thoracic Society 2006;3:465-6.
  132. O'Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ and Knobil K. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006;130:647-56.
  133. Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ, Danhof M, Rabe KF and Pasqua OE. Markers of disease severity in chronic obstructive pulmonary disease. Pulmonary Pharmacology and Therapeutics 2006;19:189-99.
  134. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS and Celli BR. C-reactive protein in patients with COPD, control smokers, and nonsmokers. Thorax 2006;61:23-8.
  135. Celli B, Cross S, Grossman R, Kardos P, Myrseth SE, Rodriguez-Roisin R and Vestbo J. Improving the care of COPD patients - Suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD. Primary Care Respiratory Journal 2006;15:139-42.
  136. Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ, Danhof M, Rabe KF and Della Pasqua OE. Markers of exacerbation severity in chronic obstructive pulmonary disease. Respiratory Research 2006;7:74-86.
  137. Celli BR. Change in the BODE index reflects disease modification in COPD: Lessons from lung volume reduction surgery. Chest 2006;129:835-6.
  138. Damarla M, Celli B, Mullerova H and Pinto-Plata V. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respiratory Care 2006;51:1120-4.
  139. Celli BR. Chronic obstructive pulmonary disease: From unjustified nihilism to evidence-based optimism. Proceeding of the American Thoracic Society 2006;3:58-65.
  140. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, Aguirre-Jaime A, Celli BR and Casanova C. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. European Respiratory Journal 2006;27:902-7.
  141. Gately R, Boardman S, Johnson K, Navaie-Waliser M and Stevens J. The impact of telephonic nurse care management on cost reductions for patients with chronic obstructive pulmonary disease. American Public Health Association, Public Health Nursing, Boston, MA, November 2006.
  142. Celli B. COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1. Chest 2006;129:5-6.
  143. Celli BR, Halbert RJ, Nordyke RJ and Schau B. Airway obstruction in never smokers: Results from the third National Health and Nutrition Examination Survey. American Journal of Medicine 2005;118:1364-72.
  144. Celli B, ed. Pharmacotherapy of COPD. Philadelphia, PA: Lippincott; 2005.
  145. Agusti A and Celli B, eds. Enfermedad Pulmonar Obstructiva Cronica. Barcelona, Spain: Elsevier Mason; 2005.
  146. Barr RJ, Celli BR, Martinez FJ, Ries AL, Rennard SI, Reilly JJ Jr, Sciurba FC, Tomashow BM and Wise RA. Physician and patient perceptions in COPD: The COPD resource network needs assessment survey. American Journal of Medicine 2005;118:1415.
  147. Celli BR, Calverley PM, Rennard SI, Wouters EF, Agusti A, Anthonisen N, Macnee W, Jones P, Pride N, Rodriguez-Roisin R, Rossi A and Wanner A. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respiratory Medicine 2005;99:1546-54.
  148. Celli B, Goldstein R, Jardim J and Knobil K. Future perspectives in COPD. Respiratory Medicine 2005;99:S41-8.
  149. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V and Celli BR. Inspiratory-to-total lung capacity ratio redicts mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2005;171:591-7.
  150. Decramer M, Celli B, Tashkin D, Pawels R, Burkhart D, Cassino C and Kesten S. Clinical trial design considerations in assessing long-term functional impacts of tiotropium. COPD 2004;1:303-12.
  151. Celli BR and MacNee W. Standards for the diagnosis and treatment of COPD. European Respiratory Journal 2004;23:932-46.
  152. Pinto-Plata VM, Cote C, Cabral H, Taylor J and Celli BR. The 6 –minute walk distance: Change over time and value as a predictor of survival in severe COPD. European Respiratory Journal 2004;1:28-33.
  153. Celli B. Chronic respiratory failure after lung resection: The role of pulmonary rehabilitation. Thoracic Surgery Clinics 2004;14:417-29.
  154. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V and Cabral HJ. The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. New England Journal of Medicine 2004;350:1005-12.
  155. Casanova C, Baudet JS, del Valle Velasco M, Martin JM, Aguirre-Jaime A, Pablo de Torres J and Celli BR. Increased gastro-oesophageal disease in patients with severe COPD. European Respiratory Journal 2004;23:841-5.
  156. Miller J, Berger R, Malthaner R, Celli B, Goldsmith C, Ingenito E, Higgins D, Bagley P, Cox G and Wright C. Lung volume reduction surgery vs. medical treatment for patients with advanced emphysema. Chest 2005;127(4):1166-77.
  157. Heijdra Y, Pinto-Plata V, Frants R, Rassulo J, Kenney L and Celli B. Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 2003;124:75-82.
  158. Celli B, ZuWallack R, Wang S and Kesten S. Improvement of inspiratory capacity and hyperinflation with tiotropium in COPD patients with severe hyperinflation. Chest 2003;124(5):1743-8.
  159. Gonzalez C, Servera E, Celli B, Diaz J and Marin J. A simple noninvasive pressure-time index at the mouth to measure respiratory load during acute exacerbation of COPD. A comparison with normal volunteers. Respiratory Medicine 2003;97:415-20.
  160. Celli BR, Halbert RJ, Isonaka S and Schau B. Population impact of different definitions of airways obstruction. European Respiratory Journal 2003;22:268-73.
  161. Castaldo R, Celli B, Gomez F, LaValle N, Souhrada J and Hanrahan J. A comparison of 5-Days courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clinical Therapeutics 2003;25:1-15.
  162. Celli B, Halpin D, Hepburn R, Byrne N, Keating ET and Goldman M. Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: Results of a 3-months comparative study using the Breathlessness, Cough and Sputum Scale (BCSS). Respiratory Medicine 2003;97:S35-43.
  163. de Torres J, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R and Celli BR. Power of outcome measures to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002;121:1092-8. 164. Celli B and Frants R. Circulatory effects of COPD. In: Scharf, Pinsky, Magder, eds. Respiratory-circulatory interactions in health and disease. New York, New York: Marcell and Dekker Inc.; 2002:26:681-703.
  164. Celli BR. Upper extremity exercise in rehabilitation of COPD. In: Jobin, Maltais, Poirier, LeBlanc and Simard, eds. Advancing the frontiers of cardiopulmonary rehabilitation. Champlain, IL: Human Kinetics; 2002:67-89.
  165. Celli B.R. Pathophysiology of COPD. In: Aliverti, Brusasco, Macklem and Pedotti, eds. Mechanics of Breathing. Milano, Italia: Springer-Verlag; 2002:218-31.
  166. Celli B. Oxygen therapy. In: Barnes, Drazen, Rennard and Thomson, eds. Asthma and COPD. Amsterdam: Academic Press; 2002, 2008;55:587-97.
  167. Marin J, Carrizo S, Gascon M, Sanchez A, Gallego B and Celli B. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the 6 minute walk test in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2001;163:1395-1400.
  168. Snow V, Lascher S, Mottur-Pilson C, Almernoff P, Auwaerter P, Braman S, Celli B, Fein A, Fiel S, Hudgel D, Levine S, Mandel M, Tunis S and Pach P. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine 2001;134:595-9.
  169. Pinto-Plata V and Celli B. Chronic obstructive lung disease. In: Parsons and Heffner, eds. Pulmonary/Respiratory Therapy Secrets, 2nd ed. Philadelphia, PA: Hanley & Belfus; 2001:18:102-8.
  170. Montes de Oca M and Celli BR. Los musculos perifericos en la EPOC: Descondicionamineto o miopatia? Archivos de Bronconeumologia 2001;37:82-6.
  171. Celli B. The importance of spirometry in COPD and asthma. Chest 2000;117(Suppl 2):15S-9S.
  172. Montes de Oca M and Celli B. Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2000;161:880-5.
  173. Celli BR. Monitoring the progression of chronic obstructive pulmonary disease: Time for a new staging system. European Respiratory Review 1999;9:165-8.
  174. Celli B, Benditt J and Albert R. Chronic obstructive pulmonary disease. In: Albert, Spiro and Jett, eds. Comprehensive Respiratory Medicine. London: MOSBY; 1999:7:37.1-.24.
  175. Marin J, Montes De Oca M, Rassulo J and Celli BR. Ventilatory drive at rest and perception of exertional dyspnea in severe COPD. Chest 1999; 115:1293-1300.
  176. Celli BR. Training in the rehabilitation of pulmonary patients with chronic obstructive pulmonary disease. Monaldi Archives for Chest Disease 1998;53;438-49.
  177. Celli BR. Pulmonary rehabilitation and lung volume reduction surgery in the treatment of patients with chronic obstructive pulmonary disease. Monaldi Archives for Chest Disease 1998;53:471-9.
  178. Montes de Oca M and Celli BR. Mouth occlusion pressure, CO2 response and hypercapnia in severe obstructive pulmonary disease. European Respiratory Journal 1998;12:666-71.
  179. Celli B. Pulmonary rehabilitation for COPD: A practical approach for improving ventilatory condition. Postgraduate Medicine 1998;103:159-76.
  180. Celli BR. Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? American Journal of Respiratory and Critical Care 1997;155:781-3.
  181. Celli BR, Cosentino A, Fiel S and Petty TL. The challenge of COPD. Therapeutic strategies that work. Patient Care 1997;31:101-18.
  182. Celli BR. Standards for the optimal management of COPD. Chest 1998;113(Suppl):283S-7S.
  183. Montes de Oca M, Celli B and Rasullo J. Progresion de la disfuncion de los musculos respirato rios en pacientes con enfermedad obstructiva cronica severa. Archivos de Bronconeumologia 1997;33:561-5.
  184. Lee J and Celli B. Chronic obstructive pulmonary disease. In: Sahn and Heffner, eds. Critical Care Pearls. Philadelphia, PA: Hanley and Belfus Inc.; 1997:73-5.
  185. Celli BR. ATS standards for the optimal management of chronic obstructive pulmonary disease. Respirology 1997;2:200-4.
  186. Celli BR, Montes de Oca M, Mendez R and Stetz J. Lung reduction surgery in severe COPD decreases central drive and ventilatory response to CO2. Chest 1997;112:902-6.
  187. Epstein SK, Celli BR, Martinez FJ, Couser J, Roa J, Pollock M and Benditt JO. Arm training reduces the VO2 and VE cost of unsupported arm exercise and elevation in chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation 1997;17:171-7.
  188. Montes de Oca M, Rassulo J and Celli B. Respiratory muscle function and cardiopulmonary response to exercise in severe COPD. American Journal of Respiratory and Critical Care Medicine 1996;154:1284-9.
  189. Celli BR, Cosentino A, Fiel S and Petty TL. COPD: Step by step through the work-up. Patient Care 1996;31:21-52.
  190. Celli B. ATS standards for the diagnosis and care of patients with COPD. European Respiratory Review 1996;6:276-81.
  191. Lee J and Celli B. Chronic obstructive lung disease. In: Parsons and Heffner, eds. Pulmonary Respiratory Therapy Secrets. Philadelphia, PA: Hanley and Belfus Inc.; 1996:102-6.
  192. Celli B and Gottlieb S. Biofeedback and upper extremity exercise in chronic obstructive pulmonary disease. In: Bach, ed. Pulmonary Rehabilitation. Philadelphia, PA: Hanley & Belfus Mosby; 1996:9:109-22.
  193. Celli BR. Current thoughts regarding treatment of COPD. Medical Clinics of North America 1996;80:589-609.
  194. Celli BR. Pathophysiology of chronic obstructive pulmonary disease. Chest Surgery Clinics of North America 1995;5:623-34.
  195. Celli BR. Standards for the diagnosis and treatment of patients with COPD. American Journal of Respiratory and Critical Care Medicine 1995;152(Suppl):S78-S121.
  196. Isea J, Poyant D, O'Donnell C, Faling J, Karlinsky J and Celli B. Controlled trial of continuous irrigation - suction catheter versus conventional intermittent suction catheter in clearing bronchial secretions from ventilated patients. Chest 1993;103:7-30.
  197. Pollock M, Roa J, Benditt J and Celli BR. Estimation of ventilatory reserve by stair climbing: A study in patients with chronic airflow obstruction. Chest 1993;104;1378-83.
  198. Epstein S and Celli BR. Exercising the patient with COPD. Cleveland Clinic Journal 1993;60:119-28.
  199. Celli BR. Respiratory muscle function in COPD. Monaldi Archive of Chest Diseases 1993;5;498-505.
  200. Chalker R, Celli BR, Habib RH and Jackson A. Respiratory system input impedance from 4-256 Hz in normals and patients with chronic airflow obstruction comparisons and correlations with spirometry. American Review of Respiratory Disease 1992;146;570-6.
  201. Tarpy S and Celli B. When should oxygen be prescribed in patients with chronic obstructive pulmonary disease? Medicine, Exercise, Nutrition and Health 1992;1:331-42.
  202. Martinez F, Couser J and Celli BR. Respiratory response to arm elevation in patients with chronic airflow obstruction. American Review of Respiratory Disease 1991;143:476-80.
  203. Martinez F, Couser J and Celli BR. Factors that determine ventilatory muscle recruitment in patients with chronic airflow obstruction. American Review of Respiratory Disease 1990;142;276-82.
  204. Celli BR, Lee H, Criner GJ, Bermudez M, Rassulo J, Gilmartin M, Miller G and Make B. Controlled trial of external negative pressure ventilation in patients with severe chronic airflow obstruction. American Review of Respiratory Disease 1989;140:1251-6.
  205. Criner G and Celli BR. Ventilatory muscle recruitment in exercise with O2 in obstructed patients with mild hypoxemia. Journal of Applied Physiology 1987;63(1):195-200.
  206. Criner G, Rassulo J, Make B and Celli B. Respiratory muscle fatigue induced by chronic tracheostomy tube placement in a patient with COPD. Chest 1987;91:139-41.
  207. Dricks M, Craven D, Celli B, Manning M, Burke R, Garvin G, Kunches L and McCabe W. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: The role of Gastric Colonization. New England Journal of Medicine 1987;317:1376-82.
  208. Celli BR, Rassulo J and Make B. Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. New England Journal of Medicine 1986;314:1485-90.
  209. Celli BR, Rassulo J, Berman JS and Make B. Respiratory consequences of abdominal hernia in a patient with COPD. American Review of Respiratory Disease 1985;131:178-80.
  210. Celli BR. Chronic obstructive pulmonary disease: An overview. American Family Practice Annals 1985;3:49-60.
Errors occurred while processing template[pageRendered/page.st]:
StringTemplate Error: Can't parse chunk: {settingHomePageKBArticle}" target="_blank">Learn how.</a></li>
<li>If you have already selected a front page, make sure it is enabled. Click on the Cubes icon (top right) and then click the "enable page" button.</li>
</ol>
</div>

: expecting '"', found '<EOF>'
StringTemplate Error: problem parsing template 'pageRendered/noDefaultModule': null
StringTemplate Error: problem parsing template 'pageRendered/noDefaultModule': null